| | | | | | Notes | Dec. 31, 2019 | | Dec. 31, 2018 | | EGP Thousands | | EGP Thousands | | | | | | Net profit for the period | | 11,803,555 | | 9,555,755 | Other comprehensive income items that will not be reclassified to the Profit or Loss: | | | | | Net change in fair value of debt instruments measured at fair value through other comprehensive income | | 212,967 | | 57,026 | Other comprehensive income items that is or may be reclassified to the profit or loss: | | | | | Net change in fair value of debt instruments measured at fair value through other comprehensive income | | 5,944,586 | | (2,164,847) | Expected credit loss for fair value of debt instruments measured at fair value through other comprehensive income | | (184,921) | | - | Total other comprehensive income for the year | | 17,776,187 | | 7,447,934 | | | | | | | | | | | Separate cash flow for the period ended December 31, 2019 | | Notes | Dec. 31, 2019 | | Dec. 31, 2018 | | | EGP Thousands | | EGP Thousands | | | | | | Cash flow from operating activities | | | | | Profit before income tax | | 16,537,441 | | 13,052,594 | Adjustments to reconcile net profit to net cash provided by operating activities | | | | | Fixed assets depreciation | 24 | 576,544 | | 390,830 | Impairment charge for credit losses (Loans and advances to customers) | 12 | 1,610,878 | | 3,076,023 | Other provisions charges | 29 | 461,869 | | 101,501 | Impairment charge for credit losses (due from banks) | 12 | 9,503 | | - | Impairment charge for credit losses (financial investments) | 12 | (184,921) | | - | Impairment charge for other assets | 23 | (93,313) | | 316,763 | Exchange revaluation differences for financial assets at fair value through OCI | 20 | 1,593,030 | | (102,991) | Intangible assets amortization | | 238,715 | | 130,208 | Impairment charge financial assets at fair value through OCI | 21 | - | | 39,561 | Exchange differences in financial investments in subsidiary | 22 | 4,680 | | (465) | Utilization of other provisions | 29 | (28,135) | | (2,114) | Other provisions no longer used | 29 | (6,910) | | (17,670) | Exchange differences of other provisions | 29 | (110,062) | | (2,269) | (Profits) losses from selling property, plant and equipment | 11 | (1,439) | | (1,045) | (Profits) losses from selling financial investments | 21 | (497,894) | | (441,628) | Shares based payments | | 464,539 | | 408,346 | Operating profits before changes in operating assets and liabilities | | 20,574,525 | | 16,947,644 | | | | | | Net decrease (increase) in assets and liabilities | | | | | Due from banks | 15 | (8,870,547) | | (13,661,577) | Treasury bills and other governmental notes | 41 | - | | 4,640,524 | Financial assets at fair value through P&L | 21 | 2,318,924 | | 4,557,492 | Derivative financial instruments | 20 | (2,910) | | (66,141) | Loans and advances to banks and customers | 18 - 19 | (14,533,328) | | (21,255,952) | Other assets | 42 | 162,502 | | (2,263,465) | Due to banks | 25 | 4,550,788 | | 5,381,901 | Due to customers | 26 | 19,143,183 | | 34,573,102 | Income tax obligations paid | | (3,625,579) | | (2,778,973) | Other liabilities | 28 | 1,894,934 | | 1,025,022 | Net cash provided from operating activities | | 21,612,492 | | 27,099,577 | | | | | | Cash flow from investing activities | | | | | Payment for purchases of subsidiary and associates | | - | | (10,575) | Payment for purchases of property, plant, equipment and branches constructions | | (1,301,415) | | (874,708) | Proceeds from selling property, plant and equipment | 11 | 1,439 | | 1,045 | Proceeds from redemption of financial assets at amortized cost | 21 | 43,937,957 | | 5,532,271 | Payment for purchases of financial assets at amortized cost | 21 | (76,516,842) | | (33,995,313) | Payment for purchases of financial assets at fair value through OCI | 21 | (50,954,311) | | (12,670,761) | Proceeds from selling financial assets at fair value through OCI | | 54,855,966 | | 2,059,341 | Net cash used in investing activities | | (29,977,206) | | (39,958,700) | | | | | | Cash flow from financing activities | | | Increase (decrease) in long term loans | 27 | (448,783) | 46,793 | Dividend paid | | (2,700,544) | (2,143,177) | Capital increase | | 105,413 | 50,315 | Net cash used in (provided from) financing activities | | (3,043,914) | (2,046,069) | | | | | | | Net increase (decrease) in cash and cash equivalent during the year | | (11,408,628) | (14,905,192) | Beginning balance of cash and cash equivalent | | 34,303,645 | 49,208,837 | Cash and cash equivalent at the end of the year | | 22,895,017 | 34,303,645 | | | | | | | | Cash and cash equivalent comprise: | | | Cash and balances with central bank | 15 | 28,273,962 | 20,058,974 | Due from banks | 16 | 28,370,183 | 46,518,892 | Treasury bills and other governmental notes | 17 | 27,634,062 | 41,999,252 | Obligatory reserve balance with CBE | 15 | (22,397,310) | (13,526,763) | Due from banks with maturities more than three months | | (10,593,903) | (10,733,386) | Treasury bills with maturity more than three months | | (28,391,977) | (50,013,324) | Total cash and cash equivalent | | 22,895,017 | 34,303,645 | | | | | | |
| | | | | | | | | |